Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.

Sung Tae Kim, Insuk Sohn, Young S. Park, AmirAli Talasaz, Hyeon-Cheol Kim

PubMed · 2015 · 36 citations · 19 references

Abstract

Our data suggest that CD133(+) CRC stem cells have a distinct expression pattern and that survivin, up-regulated by differentially expressed IL-4, is a candidate biomarker for the prediction of recurrence and survival in CRC.

References

19